DK2833884T3 - Anvendelse af ccr3-inhibitorer - Google Patents

Anvendelse af ccr3-inhibitorer Download PDF

Info

Publication number: DK2833884T3
Authority: DK; Denmark
Prior art keywords: ccr3 inhibitors; ccr3; inhibitors
Prior art date: 2012-04-03

Application number

DK13713199.1T

Other languages

English (en)

Inventor

Michael Chadham Nivens

Thierry Bouyssou

Rolf Goeggel

Peter Seither

Original Assignee

Alkahest Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-04-03

Filing date

2013-04-02

Publication date

2020-08-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48040249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2833884(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-04-02 Application filed by Alkahest Inc filed Critical Alkahest Inc

2020-08-10 Application granted granted Critical

2020-08-10 Publication of DK2833884T3 publication Critical patent/DK2833884T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Structure Of Transmissions (AREA)

DK13713199.1T 2012-04-03 2013-04-02 Anvendelse af ccr3-inhibitorer DK2833884T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12162937		2012-04-03
PCT/EP2013/056864 WO2013149986A1 (en)	2012-04-03	2013-04-02	Use of ccr3-inhibitors

Publications (1)

Publication Number	Publication Date
DK2833884T3 true DK2833884T3 (da)	2020-08-10

Family

ID=48040249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK13713199.1T DK2833884T3 (da)	2012-04-03	2013-04-02	Anvendelse af ccr3-inhibitorer

Country Status (28)

Country	Link
US (5)	US20130261153A1 (da)
EP (3)	EP2833884B1 (da)
JP (2)	JP2015512432A (da)
KR (4)	KR20200044988A (da)
CN (2)	CN104220073A (da)
AU (1)	AU2013245027B2 (da)
BR (1)	BR112014023795B1 (da)
CA (1)	CA2869269C (da)
CL (1)	CL2014002523A1 (da)
CY (1)	CY1123222T1 (da)
DK (1)	DK2833884T3 (da)
EA (1)	EA032263B1 (da)
ES (2)	ES2987267T3 (da)
HR (1)	HRP20201165T1 (da)
HU (1)	HUE051648T2 (da)
IL (1)	IL234262A (da)
IN (1)	IN2014DN06989A (da)
LT (1)	LT2833884T (da)
MX (1)	MX2014011786A (da)
NZ (1)	NZ628882A (da)
PH (1)	PH12014502239A1 (da)
PL (1)	PL2833884T3 (da)
PT (1)	PT2833884T (da)
RS (1)	RS60665B1 (da)
SI (1)	SI2833884T1 (da)
SM (1)	SMT202000499T1 (da)
WO (1)	WO2013149986A1 (da)
ZA (1)	ZA201406082B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8278302B2 (en)	2009-04-08	2012-10-02	Boehringer Ingelheim International Gmbh	Substituted piperidines as CCR3 antagonists
UA109290C2 (uk)	2010-10-07	2015-08-10		Спільні кристали і солі інгібіторів ccr3
US8680280B2 (en)	2012-04-02	2014-03-25	Boehringer Ingelheim International Gmbh	Process for the manufacturing of CRR inhibitors
US20130261153A1 (en) *	2012-04-03	2013-10-03	Boehringer Ingelheim International Gmbh	Use of ccr3-inhibitors
US10213421B2 (en)	2012-04-04	2019-02-26	Alkahest, Inc.	Pharmaceutical formulations comprising CCR3 antagonists
EP3449866B1 (en)	2016-11-24	2021-10-20	Kirishima Seiko Co., Ltd.	Orthodontic appliance
BR112019020798A2 (pt) *	2017-04-05	2020-04-28	Alkahest Inc	métodos e composições para tratamento de danos associados ao envelhecimento usando inibidores de ccr3
EP4245295A3 (en) *	2017-04-05	2023-11-01	Alkahest, Inc.	Compounds and pharmaceutical compositions for use in treating retina-associated disease using ccr3-inhibitors
KR20200067859A (ko) *	2017-10-13	2020-06-12	알카헤스트 인코포레이티드	Ccr3-억제제를 사용한 소양증, 건조증, 및 관련 질환을 치료하기 위한 방법 및 조성물
MX2020011114A (es)	2018-05-15	2021-01-29	Alkahest Inc	Tratamiento de enfermedades asociadas con el envejecimiento con moduladores de la leucotrieno a4 hidrolasa.
EA202190463A1 (ru) *	2018-09-26	2021-06-29	Алкахест, Инк.	Способы и композиции для лечения ассоциированных со старением нарушений с применением ccr3-ингибиторов
CA3180401A1 (en) *	2020-06-11	2021-12-16	Bartosz SIKORSKI	Methods of improving retina-associated disease outcome using ccr3-inhibitors
CA3221177A1 (en)	2021-11-01	2023-05-04	Meghan Kerrisk Campbell	Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6339087B1 (en) *	1997-08-18	2002-01-15	Syntex (U.S.A.) Llc	Cyclic amine derivatives-CCR-3 receptor antagonists
GB2361704C (en) *	2000-03-03	2006-08-02	Cambridge Antibody Tech	Human antibodies against eotaxin and their use
US20020151064A1 (en) *	2001-02-07	2002-10-17	Children's Hospital Medical Center	Regulation of CCR3 expression
WO2006083390A2 (en) *	2004-12-07	2006-08-10	Children's Hospital Medical Center	Eotaxin-3 in eosinophilic esophagitis
US8008092B2 (en) *	2007-10-09	2011-08-30	University Of Kentucky Research Foundation	CCR3 inhibition for ocular angiogenesis and macular degeneration
WO2010069979A1 (en) *	2008-12-16	2010-06-24	Nycomed Gmbh	Pyran derivatives as ccr3 modulators
EP2236520A1 (en) *	2009-03-31	2010-10-06	Leukocare Ag	Stabilizing composition for immobilized biomolecules
US8278302B2 (en)	2009-04-08	2012-10-02	Boehringer Ingelheim International Gmbh	Substituted piperidines as CCR3 antagonists
WO2010138591A1 (en) *	2009-05-26	2010-12-02	University Of Kentucky Research Foundation	Ccr3 and its ligands are therapeutic and diagnostic targets for neovascular age-related macular degeneration
UA109290C2 (uk) *	2010-10-07	2015-08-10		Спільні кристали і солі інгібіторів ccr3
US20130261153A1 (en) *	2012-04-03	2013-10-03	Boehringer Ingelheim International Gmbh	Use of ccr3-inhibitors
US10213421B2 (en) *	2012-04-04	2019-02-26	Alkahest, Inc.	Pharmaceutical formulations comprising CCR3 antagonists
WO2020115836A1 (ja) *	2018-12-05	2020-06-11	東浜工業株式会社	ブロワー装置

2013
- 2013-03-27 US US13/851,564 patent/US20130261153A1/en not_active Abandoned
- 2013-04-02 DK DK13713199.1T patent/DK2833884T3/da active
- 2013-04-02 CA CA2869269A patent/CA2869269C/en active Active
- 2013-04-02 SM SM20200499T patent/SMT202000499T1/it unknown
- 2013-04-02 EP EP13713199.1A patent/EP2833884B1/en active Active
- 2013-04-02 KR KR1020207011392A patent/KR20200044988A/ko not_active Ceased
- 2013-04-02 HU HUE13713199A patent/HUE051648T2/hu unknown
- 2013-04-02 RS RS20200868A patent/RS60665B1/sr unknown
- 2013-04-02 NZ NZ628882A patent/NZ628882A/en unknown
- 2013-04-02 AU AU2013245027A patent/AU2013245027B2/en active Active
- 2013-04-02 IN IN6989DEN2014 patent/IN2014DN06989A/en unknown
- 2013-04-02 SI SI201331753T patent/SI2833884T1/sl unknown
- 2013-04-02 EA EA201401083A patent/EA032263B1/ru unknown
- 2013-04-02 WO PCT/EP2013/056864 patent/WO2013149986A1/en active Application Filing
- 2013-04-02 KR KR1020227031439A patent/KR20220132012A/ko not_active Ceased
- 2013-04-02 PT PT137131991T patent/PT2833884T/pt unknown
- 2013-04-02 LT LTEP13713199.1T patent/LT2833884T/lt unknown
- 2013-04-02 CN CN201380016333.7A patent/CN104220073A/zh active Pending
- 2013-04-02 PL PL13713199T patent/PL2833884T3/pl unknown
- 2013-04-02 CN CN201910406245.7A patent/CN110384699A/zh active Pending
- 2013-04-02 KR KR1020147027679A patent/KR20140144200A/ko not_active Ceased
- 2013-04-02 BR BR112014023795-6A patent/BR112014023795B1/pt active IP Right Grant
- 2013-04-02 KR KR1020217015686A patent/KR20210063481A/ko not_active Ceased
- 2013-04-02 JP JP2015503847A patent/JP2015512432A/ja active Pending
- 2013-04-02 MX MX2014011786A patent/MX2014011786A/es unknown
- 2013-04-02 EP EP24158785.6A patent/EP4389217A3/en active Pending
- 2013-04-02 EP EP20174399.4A patent/EP3763369B1/en active Active
- 2013-04-02 ES ES20174399T patent/ES2987267T3/es active Active
- 2013-04-02 ES ES13713199T patent/ES2811554T3/es active Active
2014
- 2014-08-19 ZA ZA2014/06082A patent/ZA201406082B/en unknown
- 2014-08-24 IL IL234262A patent/IL234262A/en active IP Right Grant
- 2014-09-24 CL CL2014002523A patent/CL2014002523A1/es unknown
- 2014-10-03 PH PH12014502239A patent/PH12014502239A1/en unknown
- 2014-12-15 US US14/570,298 patent/US20150099783A1/en not_active Abandoned
2015
- 2015-11-30 US US14/953,480 patent/US20160081998A1/en not_active Abandoned
2017
- 2017-07-25 US US15/658,918 patent/US20170319567A1/en not_active Abandoned
- 2017-12-22 JP JP2017246173A patent/JP2018080183A/ja not_active Withdrawn
2020
- 2020-07-23 CY CY20201100678T patent/CY1123222T1/el unknown
- 2020-07-27 HR HRP20201165TT patent/HRP20201165T1/hr unknown
- 2020-08-19 US US16/997,772 patent/US20200375971A1/en not_active Abandoned

Also Published As

Publication number	Publication date
SMT202000499T1 (it)	2020-11-10
RS60665B1 (sr)	2020-09-30
PL2833884T3 (pl)	2020-11-02
EP4389217A2 (en)	2024-06-26
EA201401083A1 (ru)	2015-03-31
CL2014002523A1 (es)	2015-01-23
EP4389217A3 (en)	2024-08-28
ES2811554T3 (es)	2021-03-12
IN2014DN06989A (da)	2015-04-10
BR112014023795B1 (pt)	2021-09-08
JP2018080183A (ja)	2018-05-24
CA2869269C (en)	2020-06-30
CN110384699A (zh)	2019-10-29
CY1123222T1 (el)	2021-10-29
BR112014023795A2 (da)	2017-06-20
PH12014502239A1 (en)	2014-12-15
US20150099783A1 (en)	2015-04-09
SI2833884T1 (sl)	2020-10-30
ES2987267T3 (es)	2024-11-14
JP2015512432A (ja)	2015-04-27
WO2013149986A1 (en)	2013-10-10
EA032263B1 (ru)	2019-05-31
KR20200044988A (ko)	2020-04-29
EP2833884B1 (en)	2020-05-20
KR20220132012A (ko)	2022-09-29
CA2869269A1 (en)	2013-10-10
US20170319567A1 (en)	2017-11-09
NZ628882A (en)	2016-05-27
BR112014023795A8 (pt)	2017-10-10
AU2013245027B2 (en)	2017-10-12
EP2833884A1 (en)	2015-02-11
HRP20201165T1 (hr)	2020-12-11
KR20140144200A (ko)	2014-12-18
ZA201406082B (en)	2019-01-30
EP3763369B1 (en)	2024-02-28
HUE051648T2 (hu)	2021-03-29
US20160081998A1 (en)	2016-03-24
CN104220073A (zh)	2014-12-17
AU2013245027A1 (en)	2014-09-11
EP3763369A1 (en)	2021-01-13
KR20210063481A (ko)	2021-06-01
IL234262A (en)	2017-10-31
MX2014011786A (es)	2014-12-05
US20200375971A1 (en)	2020-12-03
LT2833884T (lt)	2020-09-10
US20130261153A1 (en)	2013-10-03
PT2833884T (pt)	2020-08-26

Publication	Publication Date	Title
SMT201700109B (it)	2017-03-08	Inibitori di istone demetilasi
SMT201700094B (it)	2017-03-08	Composto di pirazina carbossammide
DK3080100T3 (da)	2023-02-06	Hæmmere af lysinspecifik demethylase-1
DK3357511T3 (da)	2020-08-03	Inhibitorer af t-celleaktivering
DK2833884T3 (da)	2020-08-10	Anvendelse af ccr3-inhibitorer
DK2912019T3 (da)	2021-05-25	Heteroarylhæmmere af pde4
LT2841428T (lt)	2018-12-10	Dnr-pk inhibitoriai
DK3027618T3 (da)	2020-10-12	Polymorf af syk-hæmmere
EP2683693A4 (en)	2014-10-08	ROR-GAMMA-T INHIBITORS
LT2895484T (lt)	2022-03-25	Gliukozilceramido sintazės inhibitoriai
SMT201600114B (it)	2016-08-31	Inibitori di beta-secretasi
CO7010824A2 (es)	2014-07-31	Inhibidores de aplicación viral
HUE036259T2 (hu)	2018-06-28	Inhibitor vegyületek
DK3235812T3 (da)	2019-11-25	Deutererede derivater af ivacaftor
HK1249027A1 (zh)	2018-10-26	艾杜糖-2-硫酸酯酶的純化
DK2981255T3 (da)	2022-11-14	Terapeutiske anvendelser af empagliflozin
DK3068776T3 (da)	2019-07-29	Inhibitorer af replikation af influenzavira
DK3461895T3 (da)	2020-07-20	Modulation af ube3a-ats-ekspression
DK2822568T3 (da)	2020-08-10	Anvendelser af caseinsammensætninger
DK2928477T3 (da)	2019-10-07	Anvendelse af telomeraseinhibitor imetelstat til behandling af myelofibrosis
EP2753176A4 (en)	2015-10-21	HIV INHIBITORS
EP2858975A4 (en)	2015-12-09	FBXO3 INHIBITORS
DK2834229T3 (da)	2017-11-20	Fremgangsmåde til fremstilling af ccr3-inhibitorer
DK2888228T3 (da)	2019-07-15	Inhibitorer af CD40-TRAF6 interaktion
DK2838850T3 (da)	2021-12-13	Oprensning af titantetrachlorid